The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The ASX200 is trading up around 0.55%

With strong performances from major medical companies, the healthcare sector is leading gains, up 1.2%, Discretionary follows, up nearly a per cent.

IT is the only sector to fall into the red, down a quarter of a per cent.

Telix Pharmaceuticals PharmAust Hazer Group Avita Medical

Company News

Telix Pharmaceuticals (ASX:TLX) is up around 9% after it announced positive data from the ProstACT SELECT trial of TLX-591, a therapy for the treatment of adult patients suffering prostate cancer.

This builds on prior data from the ProstACT SELECT2 trial, which demonstrated favourable safety profile and biodistribution.

TLX has been trading at $17.13

Biotechnical company PharmAust (ASX:PAA) is up 13.5% after it reappointed Dr Michael Thurn as Managing Director and Chief Executive Officer and Dr Nicky Wallis as Chief Scientific Officer.

PharmaAust said these appointments are part of a major reset as it strives to become a global leader in neurodegenerative diseases.

PAA has been trading at 21 cents.

Hydrogen and graphite producer, Hazer Group (ASX:HZR) has signed a Memorandum of understanding with Korea’s POSCO to investigate low carbon steel synergies.

POSCO is one of the world’s largest engineering companies with a heavy energy focus on investigating emission reduction strategies across its entire portfolio.

POSCO, under the MoU, will also be looking at potential ways to include the graphite that Hazer can produce in and outside its steel businesses – as well as marketing of the product.

The company plans to achieve carbon neutrality by 2050.

HZR has been trading at 47.5 cents.

And, Avita Medical (ASX:AVH) has gained around 13% after the US FDA issued the company a premarket approval for its RECELL GO skin cell harvesting device.

The system allows patients requiring burns and wound treatment to see improved healing outcomes with less donor skin needed, and reportedly less pain.

The product will be launched in burn treatment centres in June.

AVH has been trading at $3.01.

More From The Market Online
The words "ASX Market Open" appear alongside a Bear ( FALL ) with a market chart graphic floating above it. The whole image is faded yellow and orange.

ASX Today: XJO down -2% as investors presumably realise 4% CPI isn’t a good thing

When America coughs the world catches a cold, but apparently Australia’s immune system is compromised.

Broken Hill Gold obtains third gold pour from existing heap leach ore at White Dam

Broken Hill Gold has achieved a third gold pour from re-crushed material on the existing heap…
Flexiroam concept traveller using global eSIM network

This ASX comms stock is up +160% over the last year, and just turned profitable. Here’s how FlexiRoam disrupts the market

If you’ve gone travelling overseas in the last few years, you may have heard of eSIMs – in essence, a digital SIM card

Elixir Energy hits milestone at Lorelle-3H well with commencement of post-soak flow testing

Elixir Energy is set to hit a key milestone with a new phase of testing of…